Agios Pharmaceuticals, Inc. announced the pricing of their initial public offering of 5,888,888 shares of common stock. The public offering price was for US$18.00 per share. All shares in the offering are being sold solely by Agios. The company has granted the underwriters hired for the offering a 30-day option to purchase up to 883,333 extra shares from Agios at  public offering price, with a reduction of the underwriting discount. Agios' common stock will be listed on the NASDAQ Global Select Market and will trade under the ticker symbol "AGIO" starting July 24, 2013. Agios Pharmaceuticals, Inc said that they will close the offering on July 29, 2013, subjected to the customary closing conditions.

Goldman, Sachs & Co and J.P. Morgan were hired to act as the joint book-running managers for the public offering. Leerink Swan and Cowen and Company were hired by Agios Pharmaceuticals, Inc to act as the co-managers for the offering.